Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NovaXS Biotech
AddedFeb 15, 2024
UpdatedJun 18, 2026
NovaXS Biotech

NovaXS Biotech

Seed

NovaXS: A healthcare startup offering personalized in-home diagnosis, prevention, and treatment.

HQ
Berkeley, CA, US
Founded
2021
Accelerator
Techstars logoTechstars: Healthcare2023
Overview
Compare
Fundraising
Employees
Website

NovaXS Biotech is a healthcare startup dedicated to providing personalized in-home diagnosis, prevention, and treatment services. The company aims to revolutionize healthcare delivery by making it more accessible and tailored to individual needs. NovaXS focuses on leveraging advanced technology to offer comprehensive healthcare solutions directly to consumers, ensuring convenience and personalized care.

NovaXS has achieved significant milestones, including joining the Techstars Healthcare Accelerator and participating in NextMed Health. The CEO of NovaXS has been recognized as an Innovation Challenge Judge for the American Medical Women Association, highlighting the company's influence in the healthcare sector. These accomplishments underscore NovaXS's commitment to innovation and excellence in personalized healthcare.

NovaXS Biotech - Similar Companies

Nimbus Healthcare logo

Nimbus Healthcare

Bionic Health logo

Bionic Health

bionichealth.com

Rezilient Health logo

Rezilient Health

Healthtracka logo

Healthtracka

healthtracka.com

CardioCube logo

CardioCube

Brisk Health logo

Brisk Health

briskhealth.com

Liv logo

Liv

Examedi logo

Examedi

examedi.com

Trellis Health logo

Trellis Health

VivorCare logo

VivorCare

vivorcare.com

Inbound Health logo

Inbound Health

inboundhealth.com

Sprinter Health logo

Sprinter Health

sprinterhealth.com

Float Health logo

Float Health

float.health

Tomorrow Health logo

Tomorrow Health

tomorrowhealth.com

Nice Healthcare logo

Nice Healthcare

nice.healthcare

NovaXS Biotech - Quick Facts

Who are NovaXS Biotech's competitors?

Companies similar to NovaXS Biotech include Nimbus Healthcare, Bionic Health, Rezilient Health and Healthtracka.

When was NovaXS Biotech founded?

NovaXS Biotech was founded in 2021.

Where is NovaXS Biotech's headquarters located?

NovaXS Biotech's headquarters is located in Berkeley, CA, US.

When was NovaXS Biotech's last funding round?

NovaXS Biotech's most recent funding round was for $1M (USD) in March 2023.

How much has NovaXS Biotech raised to-date?

As of Mar 1, 2023, NovaXS Biotech has raised a total of $1.9M (USD).

How many employees does NovaXS Biotech have?

NovaXS Biotech has 13 employees as of Feb 5, 2024.

NovaXS Biotech - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Healthcare Services
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified